Pyrrobutamine
From Wikipedia, the free encyclopedia
 |
|
|
Pyrrobutamine
|
|
| Systematic (IUPAC) name | |
| 1-[(E)-4-(4-chlorophenyl)-3-phenylbut-2-enyl]pyrrolidine | |
| Identifiers | |
| CAS number | ? |
| ATC code | R06 |
| PubChem | |
| Chemical data | |
| Formula | C20H22ClN |
| Mol. mass | 311.848 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Pyrrobutamine is an antihistamine.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||
